Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience

PURPOSE: To investigate whether gender affects therapeutic response by exenatide twice a day (BID) in type 2 diabetes by using a database concerning patients monitored by five outpatient clinics in Tuscany, Italy. PATIENTS AND METHODS: We considered a cohort of 315 (154 male/161 female) patients exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Anichini, Roberto, Cosimi, Sabrina, Di Carlo, Alberto, Orsini, Paola, De Bellis, Alessandra, Seghieri, Giuseppe, Franconi, Flavia, Baccetti, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626369/
https://www.ncbi.nlm.nih.gov/pubmed/23630427
http://dx.doi.org/10.2147/DMSO.S42729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626369/
https://www.ncbi.nlm.nih.gov/pubmed/23630427
http://dx.doi.org/10.2147/DMSO.S42729

Ejemplares similares